Livongo to Present at Upcoming Investor Conferences
Get Alerts LVGO Hot Sheet
Join SI Premium – FREE
MOUNTAIN VIEW, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following upcoming investor conferences:
- Cowen 40th Annual Health Care Conference in Boston, MA on Tuesday, March 3 at 9:20 a.m. Eastern Time
- Morgan Stanley Technology, Media and Telecom Conference in San Francisco, CA on Wednesday, March 4 at 4:00 p.m. Pacific Time
A live webcast of both presentations, as well as archived recordings, will be available on the Investor Relations section of the company’s website, https://www.livongo.com/.
About Livongo
Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the category of Applied Health Signals to offer Members clinically-based insights that focus on the whole person and make it easier to stay healthy. Using its AI+AI engine, Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them. The Livongo approach delivers better clinical and financial outcomes while creating a different and better experience for people with chronic conditions. For more information, visit: www.livongo.com or engage with Livongo on LinkedIn or Twitter.
Investor Contact:
Alex Hughes
[email protected]
650-413-9528
Media Contact:
John Hallock
[email protected]
617-615-7712
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Miss Palestine Announces Its First National Competition in Recent History
- Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
- XRP Price Prediction: Can $2 Return as AlphaPepe Stage 20 Buyers Position for What August 19 Could Reveal?
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share